Bb Biotech | WebDisclosure

Basculer en Français

8300	Companies
115013	Keywords
55392	Articles
62492	Press releases

Home
Companies
Bb Biotech

PRESS RELEASE

published on 05/20/2024 at 12:53, 6 months 1 day ago

Edison issues review on BB Biotech (BION): A recovering sector with a healthy prognosis
Edison issues review on BB Biotech (BION), highlighting its performance improvement and optimistic outlook in the recovering biotech sector, offering investors an opportunity for acquisition at an attractive level

Investors Edison Biotech Sector BB Biotech Review
BRIEF

published on 04/26/2024 at 07:05, 6 months 25 days ago

BB Biotech AG Announces Strong First Quarter Results in 2024 Interim Report

Financial Performance Net Profit BB Biotech AG Interim Report 2024 Biotechnology Investments
BRIEF

published on 04/26/2024 at 07:05, 6 months 25 days ago

BB Biotech AG annonce de solides résultats du premier trimestre dans son rapport intermédiaire 2024

Performance Financière Bénéfice Net BB Biotech SA Rapport Intermédiaire 2024 Investissements En Biotechnologie
BRIEF

published on 04/26/2024 at 07:05, 6 months 25 days ago

BB Biotech Reports Strong First Quarter Amidst Biotech Market Uncertainties

Financial Results Biotechnology Healthcare Sector Investment Strategy BB Biotech
BRIEF

published on 04/26/2024 at 07:05, 6 months 25 days ago

BB Biotech annonce un premier trimestre solide dans un contexte d'incertitudes sur le marché de la biotechnologie

Résultats Financiers Biotechnologie Stratégie D'investissement Secteur De La Santé BB Biotechnologie
PRESS RELEASE

published on 04/26/2024 at 07:00, 6 months 25 days ago

EQS-Adhoc: BB Biotech AG publishes its interim report
BB Biotech AG publishes its interim report for the first quarter of 2024, revealing a net profit of CHF 260 million. The report includes details on the company's investment activities and performance

Investment Company Net Profit BB Biotech AG Interim Report Business Activities
PRESS RELEASE

published on 04/26/2024 at 07:00, 6 months 25 days ago

BB Biotech presents solid first-quarter results; biotech stock market impacted by shifting views on interest rates
BB Biotech reports solid first-quarter results as interest rates impact biotech stock market. Net profit reaches CHF 260 mn. Key portfolio adjustments and milestones highlighted

Interest Rates First-quarter Results BB Biotech Biotech Stock Market Portfolio Adjustments
BRIEF

published on 03/21/2024 at 18:05, 7 months 30 days ago

Les actionnaires de BB Biotech AG approuvent le dividende et élisent un nouveau président

Actionnaires Conseil D'administration Dividende Assemblée Générale Annuelle BB Biotech SA
BRIEF

published on 03/21/2024 at 18:05, 7 months 30 days ago

BB Biotech AG's Shareholders Approve Dividend and Elect New Chairman

Board Of Directors Annual General Meeting Shareholders Dividend BB Biotech AG
PRESS RELEASE

published on 03/21/2024 at 18:00, 7 months 30 days ago

Shareholders at BB Biotech AG’s AGM vote in favor of all proposals and approve the dividend of CHF 2.00 per share
Shareholders at BB Biotech AG's AGM approved a dividend of CHF 2.00 per share along with other proposals. Dr. Thomas von Planta elected as new Chairman

Shareholders Dividend AGM BB Biotech AG Dr. Thomas Von Planta

Accesswire

Published on 11/21/2024 at 15:30, 15 minutes ago

CLS Health Opens New Comprehensive Care Clinic in Sugar Creek
Published on 11/21/2024 at 15:05, 40 minutes ago

"The Not-So-Secret Lives of REAL 'Mormon' Wives" - the Eye-Opening New Book From Cedar Fort Publishing & Media - is Now Available for Purchase, Just in Time for Christmas
Published on 11/21/2024 at 15:00, 45 minutes ago

2-10 Home Buyers Warranty Makes Triumphant Entry Into Oklahoma Market
Published on 11/21/2024 at 15:00, 45 minutes ago

Sound Physicians’ ACO Achieves $22.9M Total Savings in 2023 Medicare Shared Savings Program
Published on 11/21/2024 at 15:00, 45 minutes ago

BlackBerry AtHoc "In Process" Finalization for FedRAMP High Authorization

View all ACCESSWIRE

EQS Group

Published on 11/21/2024 at 15:24, 21 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Paper Company
Published on 11/21/2024 at 15:23, 22 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Centamin plc
Published on 11/21/2024 at 15:22, 23 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 11/21/2024 at 15:20, 24 minutes ago

Form 8.3 - The Vanguard Group, Inc.: AngloGold Ashanti plc
Published on 11/21/2024 at 15:19, 25 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tritax EuroBox plc

Les Echos

Published on 11/21/2024 at 06:58, 8 hours 47 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 8 hours 47 minutes ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 8 hours 47 minutes ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 19 hours 38 minutes ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 20 hours 25 minutes ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE